Combination of Meds May Protect Heart Best
Researchers report that a combination of 3 medicines—aspirin,blood pressure-lowering beta-blockers, and cholesterol-loweringstatins—may more effectively improve the chances of survival forpatients with heart disease than any of those taken alone. A studyconducted at the University of Nottingham, England, showed thatthe combination resulted in an 83% reduction in deaths amongthese patients. The study is the first large-scale, long-term trial to finddifferent drug combinations effective in the reduction of the risk ofdeath in patients with heart disease. Experts have previouslybelieved that a statin-aspirin-beta-blocker combination, along withfolic acid, should be developed into a single pill that could be takenby all seniors 55 and older. Although the study suggests that such apill could help patients with preexisting heart disease, there is no evidenceto suggest that this pill should be prescribed for all seniors.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025